[Use of a new cobetalactamine in the therapy of acute and chronic odontogenic processes].
Treatment of 70 patients with acute and chronic odontogenic processes for 5-35 days (mean 10.9 days) with a new cobetalactamine is reported. Rapid resolution was noted in nosological groups marked by the presence of acute infection. Particular interest is attached to the effect of the drug on chronicisting infections, such as apical granuloma, maxillary osteitis, and radicular cysts, since these forms displayed a high degree of vascular isolation, were often sustained by a mixed flora, and had been previously treated with other antibiotics. Follow-up four weeks after the conclusion of treatment showed a low incidence of recurrences that was in all events lower than in earlier experiments with chemical antibiotics. There were no instances of intolerance or allergy.
D000038:Abscess / Q000188:drug therapy; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D002908:Chronic Disease; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005491:Focal Infection, Dental / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010000:Osteitis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use*; D010482:Periapical Abscess / Q000188:drug therapy; D010484:Periapical Granuloma / Q000188:drug therapy; D011842:Radicular Cyst / Q000188:drug therapy; D014076:Tooth Diseases / Q000188:drug therapy*
D004338:Drug Combinations; D010406:Penicillins; C026549:cobetalactamines; C026550:kloxil
Impiego di una nuova cobetalattamina nella terapia di alcuni processi acuti e cronici odontogeni.